Coeptis Therapeutics Inc.
company.status.inactiveCIK 1819663fmd_1BN0WNMHX6EPG3Y35G8XA573BNManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Dec 01, 2018 to Sep 30, 2022, 15 periods
| Line item | FY2020 | FY2021 |
|---|---|---|
| Total revenues | 0 | 0 |
| Cost of revenue | 1 | 0 |
| Gross profit | (1) | 0 |
| Research and development | 0 | 0 |
| Selling, general and administrative | 6 | 14 |
| Total operating expenses | 6 | 14 |
| Operating income | (7) | (14) |
| Interest expense | 0 | 0 |
| Other non-operating income (expense) | (2) | 1 |
| Income before taxes | (9) | (13) |
| Income tax expense | 0 | 0 |
| Net income from continuing operations | (9) | (13) |
| Net income | (9) | (13) |